Alcon and LENSAR End Merger Following FTC Opposition

Overview

• The companies mutually terminated their merger, saying required U.S. approvals were unlikely before the April 23 or potential July 23 outside dates.
• LENSAR reported that the Federal Trade Commission intends to seek a court order to block the acquisition.
• LENSAR will retain the $10 million deposit provided for under the merger agreement.
• The company will release fourth-quarter and full-year 2025 results and outline its go-forward plan on March 31, with a conference call at 8:30 a.m. ET.
• LENSAR emphasized continued commercialization of its ALLY Robotic Cataract Laser and disclosed risks from transaction costs and potential litigation, while Alcon cited prolonged review delays and costs.